Takeda unveils profit surprise on Shire integration—and no U.S. Natpara supply till 2021
admin 4th February 2020 Uncategorised 0Takeda had expected to report an operating loss this fiscal year. But thanks to faster integration with Shire, it’s now looking at a possible profit. Don’t expect any contribution from Natpara in the U.S., though, Takeda’s chief financial officer said—the rare disease med won’t be available until March 2021 at the earliest.
More: Takeda unveils profit surprise on Shire integration—and no U.S. Natpara supply till 2021
Source: fierce